Management of Acute Cardiogenic Shock at the New Brunswick Heart Centre
Team-Shock
1 other identifier
observational
1,416
1 country
1
Brief Summary
In Atlantic Canada, acute myocardial infarction occurs at a rate of 2.9 % of the population and is the most common cause of cardiogenic shock (CS). In many studies, acute myocardial infarction accounts for up to 80% of the patients with CS. While there are different methods of treating patients with CS, the rate of mortality has not significantly improved over the years and remains as high as 50%. Recent studies have shown that a multi-modal, team-based approach can help improve patient outcomes; however, such a standardized approach is yet to be implemented in the New Brunswick Heart Centre (NBHC). The study aims to understand the difference in outcomes between two groups of patients treated for CS: SHOCK TEAM versus non-SHOCK TEAM. This is a retrospective study of 168 patients using the data from NBHC registry and patient charts. The study duration is 1 year. The primary outcome is hospital survival. Secondary outcomes include time from diagnosis to invasive monitoring and intervention. All data will be analyzed statistically between the two groups. The end goal of the study is to establish standard guidelines to treat CS patients and improve patient survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 13, 2021
CompletedFirst Submitted
Initial submission to the registry
April 14, 2022
CompletedFirst Posted
Study publicly available on registry
June 10, 2022
CompletedJune 10, 2022
June 1, 2022
9 months
April 14, 2022
June 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Percentage mortality
Any in-hospital mortality (within Saint John Regional Hospital, another hospital after transfer)
From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 months
Length of stay (LOS))
LOS was considered only for patients who were discharged directly home from Saint John Regional Hospital
From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 months
Discharge disposition
Discharge of patients home, transfer to another hospital or to another institution (special care home, extra-mural home)
From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 months
Percentage of missed opportunities
Missed opportunities was defined as patients who suffered significant delays or those who did not receive any intervention
From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 months
Secondary Outcomes (1)
Time from diagnosis of shock to in-hospital processes
From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 months
Study Arms (2)
At- risk group (SCAI stages A, B)
Patients who had a SCAI stage A or B at any point during their stay at the New Brunswick Heart Centre, Saint John Regional Hospital. This group was compared with the cardiogenic shock group only for preliminary analysis.
Cardiogenic shock group (SCAI stages C-E)
Patients who had a SCAI (Society for Cardiovascular Angiography and Interventions) stage C-E at any point during their stay at the New Brunswick Heart Centre, Saint John Regional Hospital. This group was used for all subsequent analyses.
Interventions
No interventions were used, as this is an observational study.
Eligibility Criteria
All patients who were admitted to the CCU at the NBHC, Saint John Regional Hospital between November 1st 2019 to November 30th 2020 were included in the study.
You may qualify if:
- \) Any patient admitted to the CCU with a diagnosis of CS (SCAI groups C, D or E) at any point during their CCU care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New Brunswick Heart Centre
Saint John, New Brunswick, E2L 4L2, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-François Légaré, M.D., Ph.D.
New Brunswick Heart Centre
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Cardiac Surgery
Study Record Dates
First Submitted
April 14, 2022
First Posted
June 10, 2022
Study Start
January 14, 2021
Primary Completion
October 13, 2021
Study Completion
October 13, 2021
Last Updated
June 10, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share